Fairmount Funds Management LLC
10 Form 4 · free tier: 48h delay
Recent Form 4 slice from EDGAR — up to 30 filings (not a full archive).
For informational purposes only. Not investment advice. Data is aggregated from public SEC and congressional disclosures. Nothing on this site is a recommendation to buy or sell any security. Public disclosure of a trade is not evidence of wrongdoing or insider trading.
Recent Form 4 trades
Open-market purchases and sales
CRESCENT BIOPHARMA, INC.
CBIO · Trade · Jul 16, 2026 · Filed · Jul 20, 2026 · filed 4 days after trade
$12,375,025
853,450 sh
Oruka Therapeutics, Inc.
ORKA · Trade · Jul 1, 2026 · Filed · Jul 1, 2026
$300,014,406
3,553,410 sh
Spyre Therapeutics, Inc.
SYRE · Trade · Jun 23, 2026 · Filed · Jun 23, 2026
$399,658,667
4,684,781 sh
Viridian Therapeutics, Inc.\DE
VRDN · Trade · May 11, 2026 · Filed · May 13, 2026 · filed 2 days after trade
$19,999,990
1,176,470 sh
Cogent Biosciences, Inc.
COGT · Trade · Mar 31, 2026 · Filed · Mar 31, 2026
$242,620,000
7,000,000 sh
Zenas BioPharma, Inc.
ZBIO · Trade · Mar 31, 2026 · Filed · Apr 1, 2026
$3,000,000
150,000 sh
Apogee Therapeutics, Inc.
APGE · Trade · Jan 22, 2026 · Filed · Jan 22, 2026
$133,525,000
1,750,000 sh
Cogent Biosciences, Inc.
COGT · Trade · Jan 22, 2026 · Filed · Jan 22, 2026
$127,400,000
3,500,000 sh
CRESCENT BIOPHARMA, INC.
CBIO · Trade · Dec 4, 2025 · Filed · Dec 8, 2025 · filed 4 days after trade
$18,237,600
1,360,000 sh
Viridian Therapeutics, Inc.\DE
VRDN · Trade · Oct 23, 2025 · Filed · Oct 27, 2025 · filed 4 days after trade
$9,999,990
454,545 sh